Recent disclosures of clinical drug candidates.
نویسندگان
چکیده
On December 6, 2007, the Society for Medicines Research held a one-day meeting entitled Recent Disclosures of Clinical Drug Candidates. The meeting brought together speakers from around the world representing both the pharmaceutical industry and academia. The meeting provided an overview of some of the latest approaches being taken in a range of therapeutic areas such as oncology, immunology, central nervous system disease, gastroenterology and antiviral research.
منابع مشابه
Repurposing of drug candidates for treatment of skin cancer
Skin cancers are highly prevalent malignancies that affect millions of people worldwide. These include melanomas and nonmelanoma skin cancers. Melanomas are among the most dangerous cancers, while nonmelanoma skin cancers generally exhibit a more benign clinical pattern; however, they may sometimes be aggressive and metastatic. Melanomas typically appear in body regions exposed to the sun, alt...
متن کاملLegal briefing: informed consent in the clinical context.
This issue's "Legal Briefing" column covers recent legal developments involving informed consent.1 We covered this topic in previous articles in The Journal of Clinical Ethics.2 But an updated discussion is warranted. First, informed consent remains a central and critically important issue in clinical ethics. Second, there have been numerous significant legal changes over the past year. We cate...
متن کاملReporting of financial conflicts of interest in clinical practice guidelines: a case study analysis of guidelines from the Canadian Medical Association Infobase
BACKGROUND Clinical practice guidelines are widely distributed by medical associations and relied upon by physicians for the best available clinical evidence. International findings report that financial conflicts of interest (FCOI) with drug companies may influence drug recommendations and are common among guideline authors. There is no comparable study on exclusively Canadian guidelines; ther...
متن کاملRecent disclosures of clinical candidates: Highlights from the Society of Medicines Research Symposium. The National Heart and Lung Institute, London, U.K. - December 1, 2016
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 125 The 2016 SMR Award lecture. The discovery, development and delivery of Opdivo . . . . . . . . . . . . . . . 125 Identifying high-quality, potent and selective inhibitors of ATM kinase for oncology therapies: Discovery of AZD-0156 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 126 Highly potent and selec...
متن کاملReview of Therapeutic Candidates for the New Coronavirus disease (COVID19)
Background: COVID-19 infectious disease caused by the sever acute respiratory syndrome coronavirus 2 (SARS-CoV-2) occurred in late November 2019 in Wuhan, China and has become a worldwide health crisis. The World Health Organization has identified COVID-19 as a public health priority of international concern. This is because the epidemic has become a pandemic and there is no effective antiviral...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Drug news & perspectives
دوره 21 3 شماره
صفحات -
تاریخ انتشار 2006